Blue Jet Healthcare Limited is an India-based company, specializing in manufacturing integrated contrast media, artificial sweeteners and its salts, as well as niche pharmaceutical intermediaries and active pharmaceutical ingredients (APIs). The Company serves as a business-to-business (B2B) company. Its integrated contrast media intermediate product categories include x-ray contrast media intermediates and MRI contrast media intermediates. Its x-ray contrast media intermediates include non-ionic APIs and ionic APIs. It manufactures saccharin and supplies to healthcare, pharma, animal feed, food and beverages industries globally. The Company's offerings include insoluble saccharin, saccharin sodium and insoluble saccharin. Its advance pharmaceutical intermediates and API products include Vanillic Acid, Docusate Sodium and TosMIC. It offers end-to-end integrated solutions from process development to commercialization of NCEs, advance intermediates, APIs and building blocks.As of 25 May 2026, BLUE JET HEALTHCARE LTD share price is ₹481.40. The stock opened at ₹443.00, compared to its previous close of ₹441.05. During today's trading session, BLUE JET HEALTHCARE LTD share price moved in the range of ₹425.55 to ₹485.15, with an average price of ₹455.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹425.55 and a high of ₹485.15. On the performance front, BLUE JET HEALTHCARE LTD share price has declined by 14.71% over the last six months and is down 39.85% on a year-on-year basis.
The market capitalization of BLUE JET HEALTHCARE LTD is ₹0 Cr, with a P/E ratio of 26.0 and a dividend yield of 0.27%.